Insider Trading March 27, 2026

Japan Post Disposes of $1.52M in Aflac Stock as Insurer Posts Mixed Q4 Results

14,200 Aflac shares sold at a weighted average of $107.03; insurer reports revenue beat but EPS miss, while Mizuho nudges up its target

By Caleb Monroe AFL
Japan Post Disposes of $1.52M in Aflac Stock as Insurer Posts Mixed Q4 Results
AFL

Japan Post Holdings Co., Ltd. sold 14,200 shares of Aflac Inc. on March 25, 2026, generating $1,519,826 at a weighted average price of $107.03. The transaction leaves Japan Post with an indirect stake of 52,018,600 Aflac shares. Aflac reported mixed fourth-quarter 2025 results with an EPS shortfall and a revenue beat, and Mizuho adjusted its price target to $107 while keeping an Underperform rating.

Key Points

  • Japan Post sold 14,200 Aflac shares on March 25, 2026, for $1,519,826 at a weighted average price of $107.03.
  • Aflac reported Q4 2025 EPS of $1.57 (versus $1.70 expected) and revenue of $4.87 billion (versus $4.28 billion expected).
  • Mizuho raised its price target to $107 from $104 while keeping an Underperform rating; Japan Post now indirectly holds 52,018,600 Aflac shares.

Japan Post Holdings Co., Ltd. completed a sale of 14,200 shares of Aflac Inc. (NYSE: AFL) common stock on March 25, 2026, according to a filing. The disposition was executed at a weighted average price of $107.03 per share, with individual trade prices ranging from $106.345 to $107.34, producing proceeds totaling $1,519,826.

The sale price was marginally above Aflac's then-current trading price of $106.41 and was noted as being closely aligned with InvestingPro's Fair Value assessment, indicating that the transaction occurred at a level consistent with that valuation view.

After the sale, Japan Post Holdings indirectly holds 52,018,600 shares of Aflac. The insurer itself is described with a market capitalization of $54.9 billion, and the company has increased its dividend for 42 consecutive years. Aflac's dividend yield at the time stood at 2.29%.

Documentation of the ownership change was signed by Nobuyasu Kato, Representative Executive Officer and Executive Vice President of Japan Post Holdings Co., Ltd., on March 27, 2026.

Separately, Aflac's fourth-quarter 2025 financials showed a mixed performance. Reported earnings per share were $1.57, below the expected $1.70 forecast, representing a 7.65% downside surprise relative to consensus. Revenue for the period came in at $4.87 billion, ahead of the $4.28 billion estimate and constituting a 13.79% upside surprise.

In related analyst activity, Mizuho revised its price target for Aflac's stock to $107 from $104 while maintaining an Underperform rating. That adjustment was described as a valuation roll-forward; despite the higher target, Mizuho still projects a negative 6% return for the stock.

The filing and subsequent notes underline a period of mixed signals for Aflac - an institutional shareholder trimming a modest position at a price roughly in line with an independent fair-value metric, and company fundamentals that beat on revenue but missed on per-share earnings, accompanied by a cautious analyst outlook.


Summary

Japan Post sold 14,200 Aflac shares on March 25, 2026, for $1,519,826 at a weighted average of $107.03. The seller now indirectly owns 52,018,600 shares. Aflac reported Q4 2025 EPS of $1.57 versus a $1.70 forecast and revenue of $4.87 billion versus a $4.28 billion forecast. Mizuho raised its price target to $107 from $104 while keeping an Underperform rating.

Key points

  • Japan Post sold 14,200 Aflac shares on March 25, 2026, for a total of $1,519,826 at a weighted average price of $107.03.
  • Aflac's Q4 2025 results were mixed: EPS of $1.57 missed expectations while revenue of $4.87 billion exceeded forecasts.
  • Sectors affected include the insurance industry and financial markets, with implications for institutional investor holdings and analyst valuation assessments.

Risks and uncertainties

  • Earnings volatility - Aflac's EPS missed expectations in Q4 2025, introducing uncertainty for investor sentiment in the insurance sector.
  • Analyst outlook - Despite a modestly higher price target, Mizuho maintains an Underperform rating and projects a negative return, reflecting lingering downside risk for the stock.
  • Market valuation - The sale occurred near a stated fair-value assessment, but the mixed financial signals could affect short-term pricing and investor confidence in insurance equities.

Risks

  • Aflac's EPS shortfall in Q4 2025 introduces earnings risk for investors in the insurance sector.
  • Analyst skepticism persists as Mizuho maintains an Underperform rating and expects a negative return despite adjusting the target.
  • Market valuation sensitivity - the transaction was near a fair-value assessment, but mixed operational results could affect short-term share pricing.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026